sk&f 97541 has been researched along with cgp 46381 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baumann, PA; Bernasconi, R; Diel, PJ; Froestl, W; Hall, RG; Maier, L; Melillo, V; Mickel, SJ; Strub, D; von Sprecher, G | 1 |
Duty, S; Johnston, T | 1 |
2 other study(ies) available for sk&f 97541 and cgp 46381
Article | Year |
---|---|
Phosphinic acid analogues of GABA. 2. Selective, orally active GABAB antagonists.
Topics: Administration, Oral; Amnesia; Animals; Cerebral Cortex; GABA-B Receptor Antagonists; gamma-Aminobutyric Acid; Hippocampus; In Vitro Techniques; Learning; Long-Term Potentiation; Magnetic Resonance Spectroscopy; Phosphinic Acids; Protein Binding; Radioligand Assay; Rats; Receptors, GABA-B; Structure-Activity Relationship | 1995 |
GABA(B) receptor agonists reverse akinesia following intranigral or intracerebroventricular injection in the reserpine-treated rat.
Topics: Animals; Baclofen; Dose-Response Relationship, Drug; GABA Agonists; GABA Antagonists; GABA-B Receptor Agonists; Globus Pallidus; Hypokinesia; Injections, Intraventricular; Male; Motor Activity; Organophosphorus Compounds; Phosphinic Acids; Rats; Rats, Sprague-Dawley; Reserpine; Substantia Nigra | 2003 |